Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer

Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer

Background: Concurrent chemoradiation with 3 weekly cisplatin (100 mg/m2) is the standard of care for locally advanced head and neck cancer. However, this regimen has been shown to be associated with lesser compliance and higher toxicities. Hence, there is a need to explore alternative concurrent ci...

Full description

Bibliographic Details
Main Authors: Lekha Madhavan Nair, R Rejnish Kumar, Kainickal Cessal Thomachan, Malu Rafi, Preethi Sara George, K M. Jagathnath Krishna, Kunnambath Ramadas
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-01-01
Series:South Asian Journal of Cancer
Subjects:
Chemoradiation
cisplatin
head and neck cancer
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=64;epage=68;aulast=Nair

Internet

http://journal.sajc.org/article.asp?issn=2278-330X;year=2017;volume=6;issue=2;spage=64;epage=68;aulast=Nair

Similar Items